Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: A meta-analysis

Lancet Oncology

Volumn 7, Issue 1, 2006, Pages 52-60

  Will, Olivia ^a   Purkayastha, Sanjay ^b   Chan, Christopher ^a   Athanasiou, Thanos ^b   Darzi, Ara W ^b   Gedroyc, Wady ^c   Tekkis, Paris P ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CALCULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IRON; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NANOSTRUCTURES; OXIDES; SENSITIVITY AND SPECIFICITY;

EID: 29744471157     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70537-4     Document Type: Article

References (55)

1. DM Koh G Brown L Temple et al Rectal cancer: Mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings-initial observations Radiology 23 2004 91-99
2. BC Nguyen W Stanford BH Thompson et al Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma J Magn Reson Imaging 10 1999 468-473
3. M Torabi SL Aquino MG Harisinghani Current concepts in lymph node imaging J Nucl Med 45 2004 1509-1518
4. SC Michel TM Keller JM Frohlich et al Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement Radiology 225 2002 527-536
5. MG Harisinghani WT Dixon MA Saksena et al MR lymphangiography: Imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10 Radiographics 24 2004 867-878
6. C Stets S Brandt F Wallis et al Axillary lymph node metastases: A statistical analysis of various parameters in MRI with USPIO J Magn Reson Imaging 16 2002 60-68
7. MF Bellin C Beigelman S Precetti-Morel Iron oxide-enhanced MR lymphography: Initial experience Eur J Radiol 34 2000 257-264
8. PM Bossuyt JB Reitsma DE Bruns et al Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative BMJ 326 2003 41-44
9. P Whiting AW Rutjes JB Reitsma et al The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 2003 25
10. S Suzuki T Moro-oka NK Choudhry The conditional relative odds ratio provided less biased results for comparing diagnostic test accuracy in meta-analyses J Clin Epidemiol 57 2004 461-469
11. ME Westwood PF Whiting J Kleijnen How does study quality affect the results of a diagnostic meta-analysis? BMC Med Res Methodol 8 2005 20
12. L Irwig AN Tosteson C Gatsonis et al Guidelines for meta-analyses evaluating diagnostic tests Ann Intern Med 120 1994 667-676
13. R Jaeschke G Guyatt DL Sackett Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group JAMA 271 1994 389-391
14. R Jaeschke GH Guyatt DL Sackett Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group JAMA 271 1994 703-777
15. Y Anzai S McLachlan M Morris et al Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck AJNR Am J Neuroradiol 15 1994 87-94
16. Y Anzai KE Blackwell SL Hirschowitz et al Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer Radiology 192 1994 709-715
17. Y Anzai CW Piccoli EK Outwater et al Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: Phase III safety and efficacy study Radiology 228 2003 777-788
18. MF Bellin C Roy K Kinkel et al Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles-initial clinical experience Radiology 207 1998 799-808
19. MF Bellin L Lebleu JB Meric Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography Abdom Imaging 28 2003 155-163
20. HE Daldrup-Link EJ Rummeny B Ihssen et al Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: Differentiation between tumor infiltration and hypercellular bone marrow Eur Radiol 12 2002 1557-1566
21. WM Deserno MG Harisinghani M Taupitz et al Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging Radiology 233 2004 449-456
22. WS Enochs G Harsh F Hochberg R Weissleder Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent J Magn Reson Imaging 9 1999 228-232
23. T Furuhata K Okita T Tsuruma et al Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas Dig Surg 20 2003 321-325
24. MG Harisinghani S Saini GJ Slater et al MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): Preliminary observations J Magn Reson Imaging 7 1997 161-163
25. MG Harisinghani S Saini PF Hahn et al MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex) Acad Radiol 5 suppl 1 1998 S167-S169
26. MG Harisinghani S Saini R Weissleder et al MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: Radiographic-pathologic correlation AJR Am J Roentgenol 172 1999 1347-1351
27. MG Harisinghani S Saini R Weissleder et al Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations J Comput Assist Tomogr 25 2001 770-776
28. MG Harisinghani JO Barentsz PF Hahn et al MR lymphangiography for detection of minimal nodal disease in patients with prostate cancer Acad Radiol 9 suppl 2 2002 S312-S313
29. MG Harisinghani J Barentsz PF Hahn et al Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2003 2491-2499
30. HT Hoffman J Quets T Toshiaki et al Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathy Laryngoscope 110 2000 1425-1430
31. PA Hudgins Y Anzai MR Morris MA Lucas Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: A phase 2 dose study AJNR Am J Neuroradiol 23 2002 649-656
32. H Imano S Motoyama R Saito et al Superior mediastinal and neck lymphatic mapping in mid- and lower-thoracic esophageal cancer as defined by ferumoxides-enhanced magnetic resonance imaging Jpn J Thorac Cardiovasc Surg 52 2004 445-450
33. K Ishiyama R Sashi Y Katayose et al Sentinel lymph node after intramammary injection of superparamagnetic iron oxide Nippon Igaku Hoshasen Gakkai Zasshi 62 2002 744-746
34. GJ Jager JO Barentsz GO Oosterhof et al Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence AJR Am J Roentgenol 167 1996 1503-1507
35. TM Keller SC Michel J Frohlich et al USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: Preliminary results Eur Radiol 14 2004 937-944
36. KH Kernstine W Stanford BF Mullan et al PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma Ann Thorac Surg 68 1999 1022-1028
37. A Laghi P Paolantonio V Panebianco et al Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: An MR finding with potential benefits in T staging of uterine neoplasms Invest Radiol 39 2004 666-670
38. MG Mack JO Balzer R Straub et al Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes Radiology 222 2002 239-244
39. TR McCauley MD Rifkin CA Ledet Pelvic lymph node visualization with MR imaging using local administration of ultra-small superparamagnetic iron oxide contrast J Magn Reson Imaging 15 2002 492-497
40. LL Muldoon P Varallyay DF Kraemer et al Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat Neuropathol Appl Neurobiol 30 2004 70-79
41. EA Neuwelt P Varallyay AG Bago et al Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours Neuropathol Appl Neurobiol 30 2004 456-471
42. HK Pannu KP Wang TL Borman DA Bluemke MR imaging of mediastinal lymph nodes: Evaluation using a superparamagnetic contrast agent J Magn Reson Imaging 12 2000 899-904
43. R Sigal T Vogl J Casselman et al Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR)-results of a phase-III multicenter clinical trial Eur Radiol 12 2002 1104-1113
44. MG Torchia R Nason R Danzinger et al Interstitial MR lymphangiography for the detection of sentinel lymph nodes J Surg Oncol 78 2001 151-156
45. P Varallyay G Nesbit LL Muldoon et al Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors AJNR Am J Neuroradiol 23 2002 510-519
46. A Vidiri L Carpanese MD Annibale et al Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide J Exp Clin Cancer Res 23 2004 53-60
47. J Ward JA Guthrie D Wilson et al Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging-comparison of optimized sequences Radiology 228 2003 709-718
48. AG Rockall SA Sohaib MG Harisinghani et al Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer J Clin Oncol 23 2005 2813-2821
49. CB Begg BJ McNeil Assessment of radiologic tests: Control of bias and other design considerations Radiology 167 1988 565-569
50. R Sharma S Saini PR Ros et al Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: Phase II clinical trial data J Magn Reson Imaging 9 1999 291-294
51. RM Pieterman JW van Putten JJ Meuzelaar et al Preoperative staging of non-small-cell lung cancer with positron-emission tomography N Engl J Med 343 2000 254-261
52. K Kinkel Y Lu M Both et al Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): A meta-analysis Radiology 224 2002 748-756
53. SH Kim SC Kim BI Choi MC Han Uterine cervical carcinoma: Evaluation of pelvic lymph node metastasis with MR imaging Radiology 190 1994 807-811
54. NC Gupta WJ Tamim GG Graeber et al Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging Chest 120 2001 521-527
55. Anderson GS Brinkmann F Soulen MC et al FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation Clin Nucl Med 28 2003 192-197